Clinical trial Recruiting at 1 site Observational Ages 45 and up

Evaluating Clareon PanOptix outcomes in cataract patients with prior myopic surgery

Official title: Visual and Refractive Outcomes of the Clareon PanOptix Pro IOL in Patients With Prior Myopic Refractive Surgery

Run by Juliette Eye Institute Research Center · NCT06555289 · Data updated 2026-11-12

This study is testing how well the Clareon PanOptix lenses work for people with cataracts who have had previous eye surgery to see if they improve vision after surgery.

More Cataract trials

Quick facts

Study typeObservational
Ages45 Years and up
SexAll
Enrollment40 (estimated)
SponsorJuliette Eye Institute Research Center
Academic / other
Locations1 site (Albuquerque, New Mexico)
StatusRecruiting
StartedOctober 23, 2024
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2026
Registry record updatedDecember 12, 2025
Trial IDNCT06555289 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 45 and older with age-related cataracts and a history of myopic PRK or LASIK.

Probably not a fit

Patients with significant ocular comorbidities or those who do not meet the inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the clinical outcomes of patients undergoing bilateral cataract surgery with the implantation of Clareon PanOptix intraocular lenses (IOL). Participants will be assessed before surgery and at one and three months post-surgery, with evaluations including visual acuity measurements and questionnaire assessments. The study aims to gather data on the effectiveness of the PanOptix IOL in patients who have previously undergone myopic refractive surgery. It is a single-center, single-arm study designed to provide insights into postoperative visual outcomes.

Why it matters

Potential benefit: If successful, this study could enhance understanding of how Clareon PanOptix IOLs perform in patients with a history of myopic refractive surgery, potentially leading to improved surgical outcomes.

How similar studies have gone: While this approach is observational, similar studies have shown promising outcomes with advanced IOLs in cataract surgery, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery.
* Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK.
* Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL.
* Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3
* Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement.

Exclusion Criteria:

* Any ocular comorbidity that might hamper postoperative visual acuity:

  * Corneal abnormality including corneal dystrophy, irregularity, and degeneration.
  * Moderate or severe dry eyes that can't be relieved after treatment.
  * History of or current anterior and posterior inflammation of any etiology.
  * Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc.
  * Glaucoma of any kind.
  * Pregnancy or lactation.
* Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK).
* Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate)
* Apple Kappa/chord mu ≥ 0.6.
* Higher order corneal aberrations at pupil diameter of 4mm: \> 0.6 total RMS, \> 0.3 coma, \> 0.3 trefoil (to exclude irregular corneas)
* Any patient requiring a limbal relaxing incision.

The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.

Where it's running

  • Juliette Eye Institute Research Center
    Albuquerque, New Mexico, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.